Quotes 5-day view Delayed Xetra
04/12/2021
04/13/2021
04/14/2021
04/15/2021
04/16/2021
Date
52.94(c)
52.95(c)
52.9(c)
52.88(c)
54(c)
Last
2 426 187
3 148 647
2 522 430
3 072 583
4 958 464
Volume
-0.75% +0.02% -0.09% -0.04% +2.12% Change
Sales 2021
41 001 M 49 120 M 49 120 M
Net income 2021
2 993 M 3 586 M 3 586 M
Net Debt 2021
39 552 M 47 383 M 47 383 M
P/E ratio 2021
17,0x
Yield 2021
3,70%
Sales 2022
42 451 M 50 856 M 50 856 M
Net income 2022
4 386 M 5 254 M 5 254 M
Net Debt 2022
35 545 M 42 583 M 42 583 M
P/E ratio 2022
13,2x
Yield 2022
3,94%
Capitalization
53 051 M 63 549 M 63 555 M
EV / Sales 2021
2,26x
EV / Sales 2022
2,09x
Nbr of Employees
95 955
Free-Float
100,0%
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Sales are distributed by product family as follows:
- agrochemicals (45.5%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (41.2%) : intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc. ;
- OTC...
Notations Surperformance© of Bayer AG
Trading Rating : Investor Rating :
News in other languages on BAYER AG
Analyst Recommendations on BAYER AG
Big business seeks unified, market-based approaches ahead of climate summit
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends BAYER AG
Short Term Mid-Term Long Term Trends Neutral Bullish Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
27
Average target price
62,78 €
Last Close Price
54,00 €
Spread / Highest target
57,4%
Spread / Average Target
16,3%
Spread / Lowest Target
-50,1%
Please enable JavaScript in your browser's settings to use dynamic charts.
1st jan. Capitalization (M$)
BAYER AG 12.14% 63 549
Canada
Deutschland
España
France
Italia
Nederland
Schweiz (DE)
United Kingdom
Report
